Johnson & Johnson COVID vaccine use in US should resume, CDC panel recommends
A CDC advisory panel recommended the J&J COVID vaccine should resume in the U.S. without additional warnings about a rare blood clot risk.
Johnson & Johnson COVID vaccine use in US should resume, CDC panel recommends
USATODAY.com
0 shares
2 views
You might like
Related news coverage
Nvidia & darpa biohybrid
Rumble
https://www.youtube.com/watch?v=0Hg7XhbXuac . No One is Talking About What Just Happened..
Advertisement
More coverage
U.S. Resumes Giving Johnson And Johnson Vaccine With Warning
Newsy
Watch VideoU.S. health officials lifted the pause on Johnson and Johnson's COVID vaccine Friday and will be adding a warning label..